Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Feed Tag: PT Changes

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Ratings
  • Markets
  • News
  • Price Target
  • Trading Ideas

JP Morgan Boosts Price Targets On These Casino Stocks

By Lisa Levin
November 28, 11:15 AM
  JP Morgan boosted the price target on Melco Resorts & Entertainment Limited (NASDAQ: MLCO) from $7 to $10. JP Morgan analyst Joseph Greff upgraded the stock from Neutral to Overweight. Melco Resorts & Entertainment shares rose 10.3% to trade at $7.27 on Monday.

LVS

Read More
1 minute read
  • Analyst Ratings
  • Markets
  • News
  • Price Target
  • Small Cap
  • Trading Ideas

Reata Pharmaceuticals To Jump 220%? Plus JP Morgan Predicts $51 For Las Vegas Sands

By Lisa Levin
November 28, 10:14 AM
Goldman Sachs boosted the price target on Reata Pharmaceuticals, Inc. (NASDAQ: RETA) from $86 to $115. Goldman Sachs analyst Madhu Kumar maintained the stock with a Buy rating. Reata Pharmaceuticals shares rose 1.9% to close at $36.03 on Friday.

EW

Read More
1 minute read
  • Analyst Ratings
  • Markets
  • News
  • Price Target

Deere To $450? Plus Jefferies Slashes PT On This Chinese EV Maker By 77%

By Lisa Levin
November 28, 9:03 AM
  BMO Capital raised Deere & Company (NYSE: DE) price target from $375 to $450. Deere shares dropped 0.8% to $438.01 in pre-market trading.

AMG

Read More
1 minute read
  • Analyst Ratings
  • Markets
  • News
  • Price Target
  • Small Cap
  • Trading Ideas

Warner Music To Rally Around 17%? Plus This Analyst Predicts $223 For Equifax

By Lisa Levin
November 25, 12:07 PM
  Morgan Stanley raised the price target on Warner Music Group Corp. (NASDAQ: WMG) from $31 to $38. Morgan Stanley analyst Benjamin Swinburne maintained an Overweight rating on the stock. Warner Music Group shares rose 1% to trade at $32.51 on Friday.

DE

Read More
1 minute read
  • Analyst Ratings
  • Markets
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Price Target
  • Trading Ideas

Lufax Holding To $3.52? These Analysts Cut Price Targets On The Chinese Company Following Q3 Earnings

By Lisa Levin
November 25, 10:07 AM
Lufax Holding Ltd (NYSE: LU) posted weaker-than-expected earnings (NYSE: LU) for its third quarter.

LU

Read More
1 minute read
  • Analyst Ratings
  • Markets
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Price Target
  • Trading Ideas

Medtronic To $85? Plus Oppenheimer Slashes PT On This Stock By 67%

By Lisa Levin
November 25, 9:31 AM
 

DE

Read More
1 minute read
  • Analyst Ratings
  • Earnings
  • News
  • Pre-Market Outlook
  • Price Target

Deere To Jump Over 33%? These Analysts Boost Price Targets On The Agricultural Equipment Manufacturer Following Q4 Results

By Lisa Levin
November 25, 9:09 AM
Deere & Company (NYSE: DE) reported posted better-than-expected Q4 EPS and sales results.

DE

Read More
1 minute read
  • Analyst Ratings
  • Markets
  • News
  • Price Target
  • Small Cap
  • Trading Ideas

Baidu To $180? Plus This Analyst Cuts PT On MacroGenics By 56%

By Lisa Levin
November 23, 11:56 AM
Mizuho cut the price target on Baidu, Inc. (NASDAQ: BIDU) from $200 to $180. Mizuho analyst James Lee maintained the stock with a Buy rating. Baidu shares rose 2.5% to trade at $97.49 on Wednesday.

AEO

Read More
1 minute read
  • Analyst Ratings
  • Earnings
  • Markets
  • News
  • Pre-Market Outlook
  • Price Target
  • Trading Ideas

Dick’s Sporting Goods To $140? These Analysts Raise Price Targets On The Sporting Goods Retailer Following Earnings Beat

By Lisa Levin
November 23, 8:53 AM
Dick's Sporting Goods Inc (NYSE: DKS) reported better-than-expected Q3 results and raised FY22 earnings guidance.

DKS

Read More
1 minute read
  • Analyst Ratings
  • Markets
  • News
  • Penny Stocks
  • Pre-Market Outlook
  • Price Target
  • Small Cap
  • Trading Ideas

Abercrombie & Fitch To Rally 21%? Plus This Analyst Predicts $237 For Autodesk

By Lisa Levin
November 23, 7:54 AM
  Telsey Advisory Group raised the price target on Abercrombie & Fitch Co. (NYSE: ANF) from $25 to $27. Abercrombie & Fitch shares fell 1.2% to $22.34 in pre-market trading.

ADSK

Posts pagination

Previous 1 … 95 96 97 … 107 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service